Francesca Simionato

HER2 loss in HER2‐positive gastric or gastroesophageal cancer after trastuzumab therapy: Implication for further clinical research

Filippo Pietrantonio, M. Caporale, Federica Morano et al. · International Journal of Cancer · 2016 · 142 citations · Full text

Her2 Loss, Tumor Biology, Gastrointestinal Oncology +13

Outcomes of Primary Chemotherapy for Borderline Resectable and Locally Advanced Pancreatic Ductal Adenocarcinoma

Laura Maggino, Giuseppe Malleo, Giovanni Marchegiani et al. · JAMA Surgery · 2019 · 132 citations · Full text

Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer: An early exploratory analysis of real‐world data

Margherita Rimini, Lorenzo Fornaro, Sara Lonardi et al. · Liver International · 2023 · 110 citations · Full text

TGFβ receptor inhibitor galunisertib is linked to inflammation- and remodeling-related proteins in patients with pancreatic cancer

Davide Melisi, Rocio García‐Carbonero, Teresa Macarulla et al. · Cancer Chemotherapy and Pharmacology · 2019 · 90 citations

Tumor Biology, Pancreatic Cancer, Immunology +5

An FGFR3 Autocrine Loop Sustains Acquired Resistance to Trastuzumab in Gastric Cancer Patients

Geny Piro, Carmine Carbone, Ivana Cataldo et al. · Clinical Cancer Research · 2016 · 84 citations